Michele Kaloss

1.0k total citations
15 papers, 824 citations indexed

About

Michele Kaloss is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Michele Kaloss has authored 15 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Michele Kaloss's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (5 papers) and CRISPR and Genetic Engineering (4 papers). Michele Kaloss is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (5 papers) and CRISPR and Genetic Engineering (4 papers). Michele Kaloss collaborates with scholars based in United States and Switzerland. Michele Kaloss's co-authors include Michael Kaleko, Neeraja Idamakanti, Theodore A Smith, Susan C. Stevenson, Sheila Connelly, Arthur W. Nienhuis, Shanthi Ganesh, P. Seshidhar Reddy, Elio F. Vanin and Laura A. King and has published in prestigious journals such as Nature Biotechnology, Journal of Virology and Virology.

In The Last Decade

Michele Kaloss

15 papers receiving 797 citations

Peers

Countries citing papers authored by Michele Kaloss

Since Specialization

Citations

This map shows the geographic impact of Michele Kaloss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Kaloss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Kaloss more than expected).

Fields of papers citing papers by Michele Kaloss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Kaloss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Kaloss. The network helps show where Michele Kaloss may publish in the future.

Co-authorship network of co-authors of Michele Kaloss

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Kaloss. A scholar is included among the top collaborators of Michele Kaloss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Kaloss. Michele Kaloss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer 2004 ·Cancer Gene Therapy ·Patricia C. Ryan, John Jakubczak, David A. Stewart, Lynda K. Hawkins, Cheng Cheng, Lori Clarke, Shanthi Ganesh, Carl Hay, (unknown), Michele Kaloss, Anthony Marinov, Sandrina Phipps, P. Seshidhar Reddy, Pamela S. Shirley, (unknown), Ling Xu, Jingping Yang, Suzanne Forry‐Schaudies, Paul L. Hallenbeck	36
2	Development of adenovirus serotype 35 as a gene transfer vector 2003 ·Virology ·P. Seshidhar Reddy, Shanthi Ganesh, (unknown), Terrence W. Brann, (unknown), Michele Kaloss, Michael Kaleko, Sheila Connelly	108
3	Receptor Interactions Involved in Adenoviral-Mediated Gene Delivery After Systemic Administration in Non-Human Primates 2003 ·Human Gene Therapy ·Theodore A Smith, Neeraja Idamakanti, Jennifer Marshall-Neff, Michele L. Rollence, Patrick M. Wright, Michele Kaloss, Laura A. King, (unknown), (unknown), (unknown), (unknown), Judit Markovits, Russette M. Lyons, Michael Kaleko, Susan C. Stevenson	98
4	An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. 2003 ·PubMed ·John Jakubczak, Patricia C. Ryan, M Gorziglia, Lori Clarke, Lynda K. Hawkins, Carl Hay, Ying Huang, Michele Kaloss, Anthony Marinov, Sandrina Phipps, (unknown), Pamela S. Shirley, (unknown), David A. Stewart, Suzanne Forry‐Schaudies, Paul L. Hallenbeck	83
5	Sustained Human Factor VIII Expression in Hemophilia A Mice Following Systemic Delivery of a Gutless Adenoviral Vector 2002 ·Molecular Therapy ·P. Seshidhar Reddy, Kiran Sakhuja, Shanthi Ganesh, Lijuan Yang, Dawn B. Kayda, Terrence W. Brann, Scott Pattison, (unknown), Neeraja Idamakanti, (unknown), Michele Kaloss, Catherine Barjot, Jeffrey S. Chamberlain, Michael Kaleko, Sheila Connelly	89
6	In Vivo Hepatic Adenoviral Gene Delivery Occurs Independently of the Coxsackievirus–Adenovirus Receptor 2002 ·Molecular Therapy ·Theodore A Smith, Neeraja Idamakanti, Helen Kylefjord, Michele L. Rollence, Laura A. King, Michele Kaloss, Michael Kaleko, Susan C. Stevenson	103
7	Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via Trimerization 2002 ·Journal of Virology ·Jin Kim, Theodore A Smith, Neeraja Idamakanti, Kathy Mulgrew, Michele Kaloss, Helen Kylefjord, Patricia C. Ryan, Michael Kaleko, Susan C. Stevenson	37
8	Breeding of retroviruses by DNA shuffling for improved stability and processing yields 2000 ·Nature Biotechnology ·Sharon K. Powell, Michele Kaloss, (unknown), (unknown), (unknown), Michael Pensiero, Edward Otto, Willem P.C. Stemmer, Nay-Wei Soong	71
9	In Vivo Evaluation of an Adenoviral Vector Encoding Canine Factor VIII: High-Level, Sustained Expression in Hemophiliac Mice 1999 ·Human Gene Therapy ·(unknown), Pamela S. Shirley, J. Andrews, Dawn B. Kayda, (unknown), Michele Kaloss, (unknown), Cheryl Cameron, Colleen Notley, Christine Hough, David Lillicrap, Michael Kaleko, Sheila Connelly	36
10	Distribution of retroviral vectors and vector producer cells using two routes of administration in rats 1999 ·Gene Therapy ·Michele Kaloss, (unknown), (unknown), Patrick Lu, Long Zhang, Gerard J. McGarrity, Edward Otto, Russette M. Lyons	7
11	In Vitro Analysis of Transformation Potential Associated with Retroviral Vector Insertions 1999 ·Human Gene Therapy ·Sharon K. Powell, Michele Kaloss, (unknown), (unknown), Zhifeng Long, Russette M. Lyons, Gerard J. McGarrity, Edward Otto	18
12	Efficacy of Antiretroviral Agents against Murine Replication-Competent Retrovirus Infection in Human Cells 1999 ·Journal of Virology ·Sharon K. Powell, (unknown), Michele Kaloss, (unknown), Russette M. Lyons, Gerard J. McGarrity, Edward Otto	16
13	Quantitative detection of cell culture Mycoplasmas by a one step polymerase chain reaction method 1996 ·Methods in Cell Science ·Edward Otto, (unknown), Michele Kaloss, Richard A. Del Giudice, Roberta S. Gardella, Gerard J. McGarrity	4
14	An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. 1995 ·PubMed ·(unknown), Suzanne Forry‐Schaudies, Edward Otto, (unknown), (unknown), Michele Kaloss, (unknown), (unknown)	33
15	Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis 1994 ·Journal of Virology ·Elio F. Vanin, Michele Kaloss, (unknown), Arthur W. Nienhuis	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact